Anika Therapeutics Inc (ANIK)

Capital Expenditure

-$5.42M

TTM · Period ending: · USD

ANIK logo

ANIK Capital Expenditure

Latest reported-$5.42M
ANIK TTM CapEx (-$100.00K → -$5.42M)
High-resolution chart · PNG

ANIK capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Anika Therapeutics Inc Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-751,405
-548,750
-505,346
-713,984
-1,280,296
-1,390,957
-1,700,000
-1,600,000
-1,400,000
-2,100,000
-2,200,000
-2,000,000
-1,600,000
-500,000
0
0
-100,000
-100,000
-200,000
-400,000
-500,000
-500,000
-400,000
-200,000
-100,000
-100,000
-100,000
-200,000
-400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.